Clorox (CLX) PT Raised to $121 at UBS Following 3Q Report; 'Investing Ahead of Anticipated Shifts to E-Com & Value-Seeking'
Tweet Send to a Friend
UBS raised its price target on Clorox (NYSE: CLX) to $121.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
